Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Gillian Stynes"'
Autor:
Shuk-Li Collings, Cinira Lefèvre, Michelle E Johnson, David Evans, Guido Hack, Gillian Stynes, Andrew Maguire
Publikováno v:
PLoS ONE, Vol 12, Iss 10, p e0185642 (2017)
This study examined characteristics and treatment persistence among patients prescribed oral anticoagulants (OACs) for stroke prevention in non-valvular atrial fibrillation (NVAF). We identified 15,244 patients (51.8% male, 72.7% aged ≥70) with NVA
Externí odkaz:
https://doaj.org/article/03838fbdf26b496e8434fc93434012fa
Autor:
Gillian Stynes, Daniel Parks, Jaro Wex, Eric S. Bradford, Rafael Alfonso-Cristancho, Sarah Cockle, Frank C. Albers, Jenny Willson, Necdet B Gunsoy
Publikováno v:
Respiratory Medicine. 123:140-148
Background Severe asthma is a heterogeneous disease. Patients with both eosinophilic and allergic asthma phenotypes may be eligible for treatment with mepolizumab and omalizumab. Evidence on the relative effectiveness of these treatments in this ‘o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eef3176ae314b8ab83642854c814024b
https://doi.org/10.1016/j.rmed.2016.12.009
https://doi.org/10.1016/j.rmed.2016.12.009
Autor:
Emanuela Castelnuovo, Michelle A. Detry, Scott M. Berry, Gillian Stynes, Jaro Wex, Henrik Svedsater, David Leather, Sally Lettis
Publikováno v:
Respiratory Research
Background Fluticasone furoate (FF)/vilanterol (VI) 100/25 mcg is a once-daily inhaled corticosteroid (ICS)/long-acting beta2 agonist (LABA) treatment approved in the United States, Canada and Europe for the long-term maintenance therapy of COPD. We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1330241474d8802cdd03bb49d17c051
https://doi.org/10.1186/s12931-015-0184-8
https://doi.org/10.1186/s12931-015-0184-8
Autor:
Scott M. Berry, Michelle A. Detry, David Leather, Emanuela Castelnuovo, Gillian Stynes, Jaro Wex, Lucy Frith, Henrik Svedsater
Publikováno v:
Asthma research and practice
Background Fluticasone furoate (FF)/vilanterol (VI) is a once-daily inhaled corticosteroid (ICS)/long-acting beta2 agonist (LABA) combination. FF/VI, 92/22mcg and 184/22mcg, are approved in Europe as maintenance therapy in persistent asthma. We repor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79eb5c88698874b649dc64a64bdba8c6
https://pubmed.ncbi.nlm.nih.gov/27965772
https://pubmed.ncbi.nlm.nih.gov/27965772
Autor:
S. Berry, Henrik Svedsater, David Leather, Sally Lettis, Gillian Stynes, Jaro Wex, M. Detry, Emanuela Castelnuovo
Publikováno v:
Value in Health. 17(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bbf465088fce175db8b4221e4782f47
Autor:
Gillian Stynes, Jaro Wex, Eric S. Bradford, Sarah Cockle, Jenny Wilson, Daniel C. Park, Rafael Alfonso-Cristancho, Frank C. Albers, Necdet B Gunsoy
Publikováno v:
Journal of Allergy and Clinical Immunology. 137:AB82
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::749ab51b1b50a4dc4d50d54fe67c80fa
https://doi.org/10.1016/j.jaci.2015.12.397
https://doi.org/10.1016/j.jaci.2015.12.397
Autor:
David Leather, Lucy Frith, Henrik Svedsater, Emanuela Castelnuovo, Gillian Stynes, Jaro Wex, M. Detry, S. Berry
Publikováno v:
Value in Health. 17:A170
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cc0c9b57656db02414d9ebf4005f389
https://doi.org/10.1016/j.jval.2014.03.992
https://doi.org/10.1016/j.jval.2014.03.992
Autor:
Chapman S; University of Bath, Bath, UK., Dale P; GSK, Brentford, UK.; Peter Dale, HEOR Solutions Ltd, Marlow, UK., Svedsater H; GSK, Brentford, UK., Stynes G; GSK, Brentford, UK.; Gillian Stynes, Bristol-Myers Squibb, Uxbridge, UK., Vyas N; Healthcare Research Worldwide, Wallingford Oxon, UK., Price D; Observational and Pragmatic Research Institute, Singapore, Singapore., Horne R; University College London, London, UK. r.horne@ucl.ac.uk.
Publikováno v:
NPJ primary care respiratory medicine [NPJ Prim Care Respir Med] 2017 Nov 14; Vol. 27 (1), pp. 61. Date of Electronic Publication: 2017 Nov 14.